This week’s episode begins with a discussion on insurer Lloyd’s of London, which is starting to attract investor attention again. Julian Hoffman, author of the story, and Mark ponder over the hopes for the market and use a near-40-year-old scandal as a guiding point of scepticism.

Jemma Slingo joins the conversation to discuss two companies covered in the second part of our Aim 100 feature, translation expert RWS and digital advertising company WPP. She explains why each company is struggling and gives her outlook on whether or not they can turn it around.

Last of all, Jennifer Johnson shines a light on two other Aim 100 companies: Chinese biopharmaceutical company Hutchmed and veterinary services provider CVS Group. The former predominantly develops oncology drugs, a well-honed focus given China’s rapidly ageing population. The latter’s shares are down 13 per cent in the past month thanks to an investigation into the industry’s competitiveness. She outlines what lies ahead for the two businesses.

The Aim 100 2023: 50 to 41

The Aim 100 2023: 40 to 31

The Aim 100 2023: 30 to 21

The Aim 100 2023: 20 to 11

The Aim 100 2023: 10 to 1

See more data on the Aim 100 here

Hosted on Acast. See acast.com/privacy for more information.

The Companies and Markets Show: Lloyd’s of London and Aim 100 Part 2

Investors' Chronicle

The Companies and Markets Show: Lloyd’s of London and Aim 100 Part 2